Intravitreal propranolol in patient with persistent clinically significant diabetic macular edema
Phase 2
- Conditions
- Refractory diabetic macular edema.Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edemaE08.311
- Registration Number
- IRCT20231027059872N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Patients with chronic and refractory DME who have been treated with Avastin at least nine times.
Exclusion Criteria
Patients who do not have proper follow-up for diabetic retinopathy
Patients without diet and medication for diabetes treatment
end stage patients for diabetic retinopathy (legal blindness, neovascular glaucoma, retinal tear, etc.)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method